Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Oct;30(10):1722-8.
doi: 10.1093/carcin/bgp177. Epub 2009 Jul 20.

Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis

Affiliations
Meta-Analysis

Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis

Malini Srinivasan et al. Carcinogenesis. 2009 Oct.

Abstract

Lung cancer is the leading cause of cancer mortality worldwide. A possible carcinogenic role of human papillomavirus (HPV) has been investigated for >20 years and has major clinical and public health implications. We performed a meta-analysis to assess the prevalence of HPV16 and HPV18 in primary lung cancers (2435 subjects from 37 published studies). The overall HPV prevalence ranged from 0.0 to 78.3% with large heterogeneity across geographic regions and histological tissue types. A higher proportion, 50% (7/14), of the European studies reported low or no HPV prevalence (0-10%) compared with the Asian studies, 22% (4/18). When the analysis was limited to HPV16 and HPV18 prevalence, a higher prevalence in Asia (HPV16 = 11.6% and HPV18 = 8.8%) than in Europe (HPV16 = 3.5% and HPV18 = 3.6%) was observed. Studies using HPV-specific primers resulted in higher prevalence rates than consensus HPV primers (HPV16: Asia = 13% and Europe = 6%; HPV18: Asia = 13% and Europe = 5%). Further studies are needed to elucidate the role of HPV in lung carcinogenesis with careful thought given to study design and laboratory detection methods for a more accurate assessment of HPV status in lung tumors.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Comparison of prevalence of HPV16 in (A) Asia and (B) Europe. (▪), study-specific HPV prevalence estimate and horizontal lines represent the study-specific CIs; the sizes of the rectangles depict how each study is weighted in the analysis and is related to the size of the study; (♦), meta-estimate of HPV prevalence and the width of the diamond represent the CI for the meta-estimate. TS, type-specific HPV primers; CS, consensus HPV primers.
Fig. 2.
Fig. 2.
Comparison of prevalence HPV18 in (A) Asia and (B) Europe. (▪), study-specific HPV prevalence estimate and horizontal lines represent the study-specific CIs; the sizes of the rectangles depict how each study is weighted in the analysis and is related to the size of the study; (♦), meta-estimate of HPV prevalence and the width of the diamond represents the CI for the meta-estimate. TS, type-specific HPV primers; CS, consensus HPV primers.

References

    1. Garcia M, et al. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
    1. Hajdu SI, et al. Discovery of human papillomavirus in carcinoma of the lung. Ann. Clin. Lab. Sci. 2008;38:3–5. - PubMed
    1. zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J. Natl Cancer Inst. 2001;93:252–253. - PubMed
    1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2002;2:342–350. - PubMed
    1. Ragin CC, et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br. J. Cancer. 2006;95:1432–1438. - PMC - PubMed

Publication types

MeSH terms